Search

everythinglearnresearchcommunity

for

Search:↓

SCD-153 shows promise as an effective topical treatment for alopecia areata.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

The document provides 70 multiple choice questions to improve haematology skills.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Alopecia patients have less GPER-1, which might affect hair loss.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Naproxen effectively treated a girl's eosinophilic pustular folliculitis when other treatments failed.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

The 2012 criteria are better for diagnosing atypical lupus cases.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Cannabinoids might help treat skin problems but more research is needed to be sure.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Melanin may help melanoma cells grow by aiding their metabolism.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Light affects skin health, aging, and cancer risk, and new light-based treatments and imaging are promising for skin care.

Blocking LFA-1 prevents hair loss in mice.

Hair follicles help attract immune cells to the skin during stress.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.